Frontlight ResearchEarly access
Trial site
Markusovszky Egyetemi Oktatokorhaz
- 2running trials
- 3closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- COPD2 trials
- Asthma1 trial
- Chronic kidney disease1 trial
- Kidney cancer1 trial
- Obesity1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 33 trials
- Status
- Completed3 trials
- Active, not recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Chiesi Hungary Ltd.2 trials
- Eli Lilly and Company1 trial
- Incyte Corporation1 trial
- Novo Nordisk A/S1 trial
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
Completed
Completed
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
Site data: ClinicalTrials.govUpdated 12 Nov 2026